HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clairol acquisition

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble to consider purchase of Bristol-Myers Squibb's Clairol, the company says in Nov. 20 SEC filing. Pharmaceutical or OTC business swap will not be a part of future discussions, P&G adds. As marketer of Pantene, Vidal Sassoon, Head & Shoulders, Physique and Pert, P&G holds a 32% dollar share in the shampoo market and 49% share in hair styling, according to Information Resources, Inc. (Chicago) for the 52 weeks ended July 16. Clairol purchase likely would require P&G hair care divestiture to pass anti-trust enforcement. The company does not currently market a leading hair color brand. Henkel announced its interest in Clairol during an analyst meeting Nov. 13 (1"The Rose Sheet" Nov. 20, p. 7)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008695

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel